After three decades of unsuccessful efforts to develop small molecules that neutralize the cancer-causing Ras proteins, an approach has been found that opens up fresh avenues for anticancer research. See Letter p.548
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis
Nature Communications Open Access 11 May 2022
-
An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer
Nature Communications Open Access 21 February 2017
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Baines, A. T., Xu, D. & Der, C. J. Future Med. Chem. 3, 1787–1808 (2011).
Ostrem, J. M., Peters, U., Sos, M. L., Wells, J. A. & Shokat, K. M. Nature 503, 548–551 (2013).
Thompson, H. Nature Med. 19, 949–950 (2013).
Rowinsky, E. K. J. Clin. Oncol. 24, 2981–2984 (2006).
Zimmermann, G. et al. Nature 497, 638–642 (2013).
Maurer, T. et al. Proc. Natl Acad. Sci. USA 109, 5299–5304 (2012).
Sun, Q. et al. Angew. Chem. Int. Edn 51, 6140–6143 (2012).
Shima, F. et al. Proc. Natl Acad. Sci. USA 110, 8182–8187 (2013).
Sequist, L. V. et al. J. Clin. Oncol. 31, 3327–3334 (2013).
Byrd, J. C. et al. N. Engl. J. Med. 369, 32–42 (2013).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Bollag, G., Zhang, C. Pocket of opportunity. Nature 503, 475–476 (2013). https://doi.org/10.1038/nature12835
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature12835
This article is cited by
-
AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis
Nature Communications (2022)
-
An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer
Nature Communications (2017)